Skip to content

Posts from 2014

Can We Prevent Psychosis?

In his blog, Dr. Insel discusses the need for early and accurate prediction of psychosis risk and for effective preventive treatments.

Continue Reading…

P-Hacking

In his blog, Dr. Insel talks about the reasons for problems with reproducibility in research, among them flawed use of statistical analysis.

Continue Reading…

Depression, Daughters, and Cellular Aging

An early sign of depression risk may provide not only a biomarker for depression but a clue to the relationship between depression and risk for medical illnesses; Dr. Insel blogs.

Continue Reading…

Atonement

In his blog for Mental Illness Awareness Week, Dr. Insel talks about the complexity of mental disorders and the need for scientists, clinicians, patients, and families to work together in searching for better treatment.

Continue Reading…

Ketamine

Ongoing research is investigating the long-term efficacy and safety of the anesthetic drug ketamine, which studies have shown can rapidly lift depressive symptoms; Dr. Insel talks about the status of ketamine in his blog.

Continue Reading…

From My Data to Mined Data

Dr. Insel discusses the importance of data sharing within the scientific community and highlights how NIMH is encouraging this process.

Continue Reading…

Childhood and Beyond - Services Research for ASD

In his blog, Dr. Insel talks about on new NIMH grants that will support research on services for people of all ages with autism.

Continue Reading…

Suicide: a Global Issue

Dr. Insel discusses a newly released World Health Organization World Suicide Report, an overview of the impact of and factors involved in suicide globally and strategies for preventing suicide.

Continue Reading…

Manipulating Memory

Neurotechnologies are making it possible to finely tune brain circuitry to manipulate memory.

Continue Reading…

Robin Williams

In referring to the recent death of Robin Williams, Dr. Insel talks about the continuing need for research to develop better treatments for serious mental illness.

Continue Reading…

Funding Research – It Takes a Village

In his blog, Dr. Insel talks about the importance of recent large philanthropic gifts to fund basic research on the brain.

Continue Reading…

Mapping the Risk Architecture of Mental Disorders

In this blog, Dr. Insel describes the results of two new genetics studies and why they are milestones in our understanding of the genetics of autism and schizophrenia.

Continue Reading…

AIDS: A Cautionary Tale

There are many obstacles to controlling illnesses such as HIV/AIDS, even when effective treatment is available; Dr. Insel talks about what is needed to ensure that effective health care is delivered to those who need it.

Continue Reading…

SAMHSA and NIMH Partner to Support Early Intervention for Serious Mental Illness

Dr. Insel and SAMHSA Administrator Pamela Hyde provide an update on funding  to support evidence-based programs that address the needs of individuals with early serious mental illness across the country.

Continue Reading…

BRAIN – Creating the Next Generation of Tools

The BRAIN Working Group unveiled an extraordinary report last week, providing a 12-year roadmap for the development of a new generation of neuroscience tools. Dr. Insel discusses how their vision provides hope for preventing and treating brain diseases and disorders.

Continue Reading…

Are Children Overmedicated?

Despite common assumptions about why more children are being treated with medications for mental disorders, the reasons remain unclear; Dr. Insel discusses the possibilities in his blog.

Continue Reading…

The Paradox of Parity

Recent changes in health care law are prompting consideration of how to ensure that treatments provided are evidence-based; Dr. Insel talks about the implications for mental health care.

Continue Reading…

May is for Meetings and Mental Health

Dr. Insel talks about common themes at some major national meetings taking place during Mental Health Awareness Month in May: changes in the health insurance climate, technology in health care, and possibilities both create for “learning” health care systems.

Continue Reading…

From Research to Practice

NIMH Director Thomas Insel and SAMHSA Administrator Pamela Hyde detail how the two agencies are implementing evidence-based early psychosis treatment programs across the United States.

Continue Reading…

National DNA Day

In a blog celebrating National DNA Day, NIMH Director Thomas Insel shares new insights about DNA, and emphasizes that, for mental disorders, DNA is less about simple heritability and more about complex mechanisms of risk.

Continue Reading…

A Misfortune Not a Crime

Dr. Insel discusses a new report that compares the number of people with serious mental illness who are incarcerated vs. the number being treated in hospitals.

Continue Reading…

BrainSpan – Mapping the Developing Brain

A new map of where and when genes are expressed in the developing human brain—the transcriptome—is already enabling scientists to gain insights into the role of risk genes in neurodevelopmental disorders. Dr. Insel talks about the implications of this work.

Continue Reading…

Autism Awareness: April 2014

Dr. Insel describes new scientific findings on autism, including new CDC prevalence data, being reported just as Autism Awareness Month begins.

Continue Reading…

Celebrating Science

At a recent awards dinner, Research!America honored patients who worked with researchers to find cures for disease; Dr. Insel shows what we can learn from these collaborations and gives an example of how genetic research can lead to effective treatment.

Continue Reading…

Brain Awareness

In a blog about Brain Awareness Month, NIMH Director Thomas Insel talks about the complexity of the brain and challenges ahead for research to understand it.

Continue Reading…

Clues to Risk and Resilience: Army STARRS

Dr. Insel talks about just published findings coming out of Army STARRS, a joint Army-NIMH effort to understand risk factors for suicide in the military.

Continue Reading…

A New Approach to Clinical Trials

NIMH is changing how it will support clinical trials. Dr. Insel summarizes the changes and the reasons behind them.

Continue Reading…

BITs and BYTEs

Dr. Insel talks about the numerous ways in which devices like computers and smartphones could be used to diagnose and treat mental disorders.

Continue Reading…

A Growth Chart for the Mind

Dr. Insel talks about a just-published paper that offers the first picture of a growth chart for cognitive development. As long-term studies add information on different facets of cognitive function, such a map has the potential to be just as vital a tool for evaluating growing children as charts for height, weight, and head circumference.

Continue Reading…

A New Research Agenda for Suicide Prevention

Dr. Insel discusses the impetus behind a newly released prioritized agenda for research on suicide prevention, and what the task force that developed the agenda hopes to achieve in terms of reducing suicide rates.

Continue Reading…

Mental Health in Davos

From the World Economic Forum in Davos, Switzerland, Dr. Insel reports that there was notable attention paid to mental health at this year’s meeting. He explains the interest of both developing and developed countries in preventing and treating mental illness.

Continue Reading…

BRAINS—A New Research Generation

Dr. Insel talks about the latest group of young investigators to receive funding through NIMH’s BRAINS program, an effort to support young scientists undertaking innovative, exploratory research.

Continue Reading…

Thinking about 2014

Dr. Insel looks forward to what’s ahead in 2014 for neuroscience and mental health: both challenges and promise.

Continue Reading…